MedPath

The Interprofessional Medication Assessment for Older Patients

Not Applicable
Conditions
Multimorbidity
Polypharmacy
Registration Number
NCT02398812
Lead Sponsor
East Savo Hospital District
Brief Summary

The objective of this pragmatic multi-center randomized controlled trial is to test the effectiveness of interprofessional medication assessment in older patients needing home care due to their diseases or decreased functional capacity in primary care. The main hypothesis is that intervention has a positive impact on functional capacity and for rational and safe use of medicines.

Detailed Description

Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.

According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
514
Inclusion Criteria

Home dwelling ≥65 years-old persons registered to public home care services and who

  1. have had dizziness, orthostatic hypotension or have fallen or
  2. use at least six medicines
Exclusion Criteria

Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Functional capacity IADL (Instrumental Activities of Daily Living)at 6 months from baseline
Functional capacity ADL (Activities of daily living;KATZ)at 6 months from baseline
Functional capacity MMSE ( Mini-mental state examination)at 6 months from baseline
Functional capacity TUG (Timed up and go)at 6 months from baseline
Functional capacity GDS (Geriatric Depression Scale)-15at 6 months from baseline
Secondary Outcome Measures
NameTimeMethod
Use of health care servicesat 6 and 12 months from baseline

visits to physician, hospital days and nursing care at home

Quality of medicinesat 6 and 12 months from baseline
Health related quality of life assessed with EQ-5Dat 6 and 12 months from baseline
Cost of medicinesat 6 and 12 months from baseline
Need of services delivered to homeat 6 and 12 months from baseline
Number of medicinesat 6 and 12 months from baseline

Trial Locations

Locations (5)

Welfare district of Forssa

🇫🇮

Forssa, Finland

Selänne Basic Health Care District

🇫🇮

Haapajärvi, Finland

Juva Health Care

🇫🇮

Juva, Finland

City of Lahti, home care

🇫🇮

Lahti, Finland

Eastern Savo Hospital District

🇫🇮

Savonlinna, Finland

Welfare district of Forssa
🇫🇮Forssa, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.